GSKGLAXF
13F holders, Q4 2024 (December 31)2holders
1new positions
1sold out
$16.86avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding GSK PLC (GLAXF) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 1 sold out. The largest holders were Aristotle Capital Management, LLC ($56.8M) and Vermillion & White Wealth Management Group, LLC ($101).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $101 |
| Exits | 1 | $62K |
All 13F filers, Q3 2024 → Q4 2024: 6 shares bought and 88,091 shares sold, net −88,085 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.11% | Reduce -2.5% | 3,366,838 | $56.8M |
| Vermillion & White Wealth Management Group, LLC | 0.00% | New | 6 | $101 |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.